Effect of Gymnema sylvestre extract on glycaemic control in type 2 diabetes: a randomised double-blind placebo-controlled trial with null primary outcome
Zuniga LY, Gonzalez-Ortiz M, Martinez-Abundis E
Published in Journal of Medicinal Food
Methodology
Randomised double-blind placebo-controlled trial of Gymnema sylvestre 300 mg twice daily for 12 weeks in patients with metabolic syndrome or dysglycaemia
Key Findings
Significant changes in insulin secretion and sensitivity indices were not observed; only modest anthropometric change occurred.
Conclusions
Standardised gymnema failed to improve insulin sensitivity or secretion in a controlled setting.
Limitations
Small sample; single centre; 12-week duration.
Supplements Studied
Significant changes in insulin secretion and sensitivity indices were not observed.
Outcomes Measured
Significant changes in insulin secretion and sensitivity indices were not observed.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.